Staging of head and neck cancer

Ronald D. Ennis, Jonathan P.s. Knisely, Lynn D. Wilson, Klaus Pantel, Hans Gath, Ernst Heissler, Gary D. Kao, Marc Rudoltz, Srdjan Denic, Joseph A. Brennan, li Mao, David Sidransky

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: Brennan et al. (Feb. 16 issue)1 are to be commended for their important and well-executed study. This is an excellent example of the use of emerging molecular-biology techniques to address important clinical questions. The clinical usefulness of the study would have been augmented, however, if the authors had provided details of the radiotherapy administered. Because radiation kills cells exponentially, its success is inversely related to the log of the clonogenic cells within the treated volume.2 The tumor-cell burden is higher in patients with positive margins, and it is for this reason that radiation decreases the rate of.

Original languageEnglish (US)
Pages (from-to)1787-1790
Number of pages4
JournalNew England Journal of Medicine
Volume332
Issue number26
DOIs
StatePublished - Jun 29 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Staging of head and neck cancer'. Together they form a unique fingerprint.

Cite this